{
    "2021-03-11": [
        [
            {
                "time": "2021-02-18",
                "original_text": "华兰生物的2020年：一份向好的业绩快报市场却为此吵翻了为什么？",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "2020年",
                        "业绩快报",
                        "市场反应"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-19",
                "original_text": "华兰生物(002007)：业绩符合预期 四价流感疫苗强劲增长",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "四价流感疫苗",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-20",
                "original_text": "群益证券(香港)--华兰生物：流感疫苗销售推动Q4业绩大增【公司研究】",
                "features": {
                    "keywords": [
                        "群益证券",
                        "华兰生物",
                        "流感疫苗",
                        "Q4业绩大增"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-21",
                "original_text": "A股异动 | 华兰生物(002007.SZ)涨超6% 2020年度净利润同比增长25%",
                "features": {
                    "keywords": [
                        "A股",
                        "华兰生物",
                        "净利润增长",
                        "2020年度"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-22",
                "original_text": "子公司疫苗业务大幅增长，华兰生物盈利增超两成",
                "features": {
                    "keywords": [
                        "子公司",
                        "疫苗业务",
                        "华兰生物",
                        "盈利增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-23",
                "original_text": "华兰生物净利润增长超两成 新冠疫苗研发受挫 分拆上市将搁浅？",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "净利润增长",
                        "新冠疫苗",
                        "分拆上市"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-24",
                "original_text": "国金晨讯】2月金融数据：融资需求旺盛驱动信贷数据继续超预期；华兰生物：流感疫苗高速放量，业绩稳健增长",
                "features": {
                    "keywords": [
                        "国金晨讯",
                        "金融数据",
                        "华兰生物",
                        "流感疫苗",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}